Mastering Revenue Cycle Management: The Key to Thriving in Dallas-Fort Worth’s Healthcare Boom

 

In an episode of Highway to Health shot at the iconic Billy Bob’s, David Kemp and healthcare veteran Kelly Strong dissected Dallas-Fort Worth’s evolution into a healthcare powerhouse, fueled by rapid population increases and a business-friendly environment. During the enlightening conversation, Strong highlighted the importance of mastering revenue cycle management and identified it as the cornerstone of DFW’s healthcare sector growth.

Strong, who currently serves as the Senior Vice President of Healthcare Operations, Revenue Cycle Improvement, underlined how DFW has not only attracted healthcare providers and startups but has also become a fertile ground for technological advancements in patient care. While outlining the challenges healthcare providers face, such as managing denials and integrating disparate technological systems, Strong’s narrative underscored the necessity of mastering revenue cycle management and adopting comprehensive strategies to ensure financial stability and foster patient trust.

Article written by MarketScale.

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…